Transcriptional blood signatures for active and amphotericin B treated visceral leishmaniasis in India

Amphotericin B provides improved therapy for visceral leishmaniasis (VL) caused by Leishmania donovani, with single dose liposomal-encapsulated Ambisome providing the best cure rates. The VL elimination program aims to reduce the incidence rate in the Indian subcontinent to <1/10,000 population/y...

Descripción completa

Detalles Bibliográficos
Autores principales: Fakiola, Michaela, Singh, Om Prakash, Syn, Genevieve, Singh, Toolika, Singh, Bhawana, Chakravarty, Jaya, Sundar, Shyam, Blackwell, Jenefer M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713396/
https://www.ncbi.nlm.nih.gov/pubmed/31419223
http://dx.doi.org/10.1371/journal.pntd.0007673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713396/
https://www.ncbi.nlm.nih.gov/pubmed/31419223
http://dx.doi.org/10.1371/journal.pntd.0007673

Ejemplares similares